Live feed
Filing
SC 13D/A
SC 13D/A0001213900-24-099811·Cartesian Therapeutics, Inc.
Schedule 13D ownership disclosure
Cartesian Therapeutics Inc
Security class unavailable · CUSIP: 816212302
Event date: 2024-11-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,481,816
- Percent of class
- 37.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-099811
- Form type
- SC 13D/A
- Filer
- Cartesian Therapeutics, Inc.
- CIK
- CIK 1453687
- Filed
- Nov 18, 2024
- Reporting period
- Nov 14, 2024
- Description
- Schedule 13D beneficial ownership